THE EFFECTS OF β-ELEMENE ON THE EXPRESSION OF MTOR, HIF-1Α, SURVIVIN IN LUNG ADENOCARCINOMA A549 CELL

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 10, Issue 4, 2013, Pages 18-23

  Tong, Enjuan ^a   Xu, Yinghui ^a   Li, Guoquan ^a   Zou, Kun ^a   Zou, Lijuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

A549; HIF 1 ; mTOR; Rhizoma Curcumae; Survivin; elemene

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ELEMENE; BETA-ELEMENE; BIRC5 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INHIBITOR OF APOPTOSIS PROTEIN; MTOR PROTEIN, HUMAN; PLANT EXTRACT; SESQUITERPENE; SURVIVIN; TARGET OF RAPAMYCIN KINASE;

A549; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ANOXIA; ARTICLE; CHEMISTRY; CURCUMA; DOWN REGULATION; DRUG EFFECT; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HIF-1Α; HUMAN; HYPOXIA; LUNG ADENOCARCINOMA; LUNG NEOPLASMS; LUNG TUMOR; METABOLISM; MTOR; PHYTOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOMA CURCUMAE; TUMOR CELL LINE; Β-ELEMENE;

A549; HIF-1Α; MTOR; RHIZOMA CURCUMAE; SURVIVIN; Β-ELEMENE;

ADENOCARCINOMA; ANOXIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; CURCUMA; DOWN-REGULATION; GENE EXPRESSION; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; TOR SERINE-THREONINE KINASES;

EID: 84900750717     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v10i4.4     Document Type: Article

References (14)

1. Chen M.W., Zhong Z.F., Wang S.P. et al (2012). Research progress in anticancer activity and novel delivery system of β-elemene. Chinese Journal of New Drugs. 21(12):1358-1361, 1388.
2. Liu J, Zhang Y, Qu J, et al. (2011). β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer, 11:183.
3. Lu J.J., Dang Y.Y., Huang M., et al. (2012). Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae. Journal of Ethnopharmacology, 143(2): 406-411.
4. Mao Y.Q., Liang X.M., Fu H.Y., et al (2012). Effects of β-elemene on α-tubulin of Human Hepatocarcinoma HepG-2 Cells. China Cancer. 21(02): 145-149.
5. Meng W., Wang Y.F., Xiong S., et al. (2007). Chinese Journal of Health Laboratory Technology. Target genes were tested by RT-PCR. 17(1): 51-52.
6. Qin Y., Guo Y.J., et al (2012). Anti-tumor effect of β-elemene in murine hepatocellular carcinoma cell line H22 depends on the level of c-Met downregulation. Biomedicine & Preventive Nutrition. 2(2): 91-98.
7. Wu Z.B., Ma S.L., Chen X.Q., et al (2012). Experiment Research on Synergistic Effect of Elemene Combined with Hyperthermia on Cell line A549 of Lung Adenocarcinoma. Chinese archives of traditional chinese medicine. 30(04): 742-744.
8. Yao Y.Q., Ding X., Jia Y.C., et al. (2008). Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation, Cancer Letters, 264(1): 8, 127-134.
9. Xu S., Xu C.F. (2006). Mechanism of multidrug resistance in tumor and reversal effect of traditional Chinese medicine: An advancement. 13(06): 404-411.
10. Zeng H.B., Liu J.G., Du X.G., Gao J.C. (2012). Suppression effect of β-elemene on the mesangial cell fibrosis. China Journal of Modern Medicine. 22(24): 27-30.
11. Zeng Z.W., Zhou G.L., Zhan X.R., et al (2010). Separation of Free Drug of Elemene Emulsion and Determination of Entrapment Efficiency by UPLC. Traditional Chinese Drug Research and Clinical Pharmacology. 21(03): 304-307.
12. Zhan H.Y., Wang K.F., Liu J., et al (2012). The anti-tumor effect of β-elemene on renal cell carcinoma cells and the mechanisms involved. Journal of Modern Oncology. 20(01): 1-3.
13. Zhao J, Li QQ, Zou B, et al. (2007). In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int J Oncol. 31(2):241-52.
14. Zhang Y., Zhao M.F., Liu Y.P., et al (2012). The effects of β-elemene on the activation of Akt and the expressions of apoptosis-related proteins in gastric cancer. Journal of Modern Oncology. 20(03): 451-454.